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Abstract
Purpose: To evaluate the diagnostic reliability of Thyroid Imaging Reporting and Data System (TI-RADS) classifica-
tions described by American College of Radiology (ACR) and Kwak et al. by calculating the risk of malignancy, to 
assess the role of TI-RADS in reducing fine-needle aspiration cytology (FNAC) of benign lesions.
Material and methods: This was a prospective study during the period from December 2017 to August 2018. Thyroid 
nodules were classified using ACR TI-RADS and TI-RADS proposed by Kwak et al. The TI-RADS categorisations 
were compared to the final diagnosis obtained by cytopathological/histopathological analysis. The risk of malignancy 
for each category was calculated. Sensitivity, specificity, and positive and negative predictive values for individual 
suspicious ultrasound features were also assessed.
Results: We evaluated a total of 127 thyroid nodules. The risk of malignancy was 0% in ACR TR1, 0% in ACR  
TR2, 6.9% in ACR TR3, 29.2% in ACR TR4, and 80% in ACR TR5 categories. The risk of malignancy for TI-RADS 
according to Kwak et al. were 0%, 0%, 21.5%, 32.4%, 100% for TI-RADS 2, 3, 4A, 4B, and 4C categories, respectively. 
Kwak TI-RADS 2 and 3 had higher sensitivity in predicting benignity compared to ACR TR1 and 2 (35.4% vs. 25.9%).
Conclusions: We found TI-RADS classification to be a reliable, non-invasive, and practical method for assessing thy-
roid nodules in routine practice. TI-RADS can safely avert avoidable FNACs in a significant proportion of benign 
thyroid lesions.
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Introduction
High-resolution sonography is a safe, valuable, nonionis-
ing, cost-effective, readily available imaging tool for iden-
tification of clinically suspected thyroid nodules. Various 
studies mentioned a prevalence of 2-6% of thyroid lesions 
on palpation, 19-35% on sonography, and 8-65% in au-
topsy data [1]. Fine-needle aspiration cytology (FNAC) 
remains pivotal for the assessment of thyroid nodules, but 
it is mildly distressing, leads to additional healthcare costs, 
and contains rare a low risk of infection and scarring [2]. 
There is a growing need to craft and utilise a dependable 
ultrasound categorisation for evaluating thyroid nodules 
and discriminating benign and malignant lesions with 
a reasonable level of certainty, through which we could also 
cut short a number of unnecessary invasive FNACs. Nu-
merous studies have proposed a thyroid imaging reporting 
and data system (TI-RADS). These studies also brought 
to light a significant number of parameters for quantita-
tive analysis of sonographic features [3,4]. However, the 
implication of these parameters differed in each study. 
We investigated the TIRADS classifications proposed in 
2011 by Kwak et al. and the 2017 ACR-TI-RADS [5,6]. 
The Kwak TI-RADS is simple and similar to BI-RADS sys-
tem, which has been in use for several years and is familiar 
to most radiologists. In ACR-TI-RADS points are given 
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for various ultrasound features in a thyroid nodule, with 
more suspicious features being awarded additional points. 
When assessing a nodule, its point total determines the 
nodule’s ACR TI-RADS stage, which varies from TR1 (be-
nign lesion) to TR5 (high suspicion of malignancy) [6,7]. 
This study was performed to prospectively investigate the 
diagnostic reliability of the aforementioned TI-RADS clas-
sification system in differentiating benign and malignant 
lesions by stratifying the risk of malignancy separately for 
individual TI-RADS categories and for various ultrasound 
features. We also wanted to estimate the decrease in the 
number of unnecessary FNACs.
Material and methods
This was a hospital-based, time-bound, prospective study 
conducted between December 2017 and August 2018 
(a period of nine months) in the Department of Radio-
diagnosis and Imaging. Institutional Ethics Committee 
approval was obtained prior to this prospective study. 
The study group comprised of 127 patients referred to the 
Department of Radiodiagnosis with clinically suspected 
thyroid nodules. These patients underwent convention-
al high-resolution sonography, and depending on the 
presence or absence of various sonographic features the 
thyroid nodules were categorised according to TI-RADS 
classification. The study required an invasive investigation 
(FNAC) to be conducted on patients. Informed consent 
was obtained from every patient. All patients who did not 
give consent for FNAC and those with bleeding diathesis 
were excluded from the study. Cases with nondiagnostic 
or indeterminate cytology results were also excluded from 
our study. In cases where thyroid biopsy/surgery were per-
formed, both the sonographic and cytopathology results 
were followed up with the final histopathology report.
Sonography technique
Ultrasound evaluation was performed on a Philips Epiq 
5G ultrasound machine using a high-frequency linear 
L18-5 probe. 
With the patient supine and neck hyper-extended, the 
entire gland was examined. Hyperextension of the neck 
was obtained by placing a pad under the shoulders. The 
neck was scanned in sagittal, transverse, and oblique sec-
tions to optimally visualise both lobes of the thyroid and 
isthmus. Imaging of the lower poles of thyroid was done 
by making the patient swallow, because this tends to raise 
the thyroid gland in the neck.
Specific attention was prospectively directed to nod-
ule characteristics (like composition, shape, echogenicity, 
margins, and echogenic foci) as those used in the ACR 
lexicon to describe thyroid nodules [7]. Points were as-
signed to each nodule for the separate categories accord-
ing to ACR-TI-RADS guidelines [6]. The sum of the 
points in each category determined the TI-RADS level 
assigned to each nodule, with TR1 indicating 0 points; 
TR2 – 2 points; TR3 – 3 points; TR4 – 4-6 points; and 
TR5 – 7 or more points. The data obtained from the ACR 
point table were used to assess the Kwak TI-RADS catego-
ry because the five suspicious features mentioned by Kwak 
et al. were a subset of the nodule characteristics described 
in the ACR lexicon. These suspicious features included: 
solid composition, marked hypoechogenicity, microcal-
cification, taller than wide shape, and irregular margins. 
Our analysis differed slightly from the lexicon of the Kwak 
TI-RADS committee with respect to margin shape. In 
studies conducted by Srinivas et al. and Chandramohan 
et al., who assessed Kwak TI-RADS, ill-defined margins 
were included under irregular margin characteristics, and 
they found statistically significant correlation with malig-
nancy [8,9]. In the ACR point table both ill-defined and 
irregular margins are categorised separately under margin 
characteristics, with the former lacking points and the lat-
ter contributing 2 points. According to the guidelines of 
the ACR TI-RADS committee, if composition, echogenic-
ity, or margins could not be determined for any reason 
like dense posterior acoustic shadowing from macrocalci-
fication, they were allocated 2, 1, or 0 points, respectively.
Ultrasound-guided fine-needle aspiration cytology 
technique
Ultrasound-guided FNAC of dominant or suspicious 
nodule was performed. The majority of FNACs were per-
formed on an outpatient basis. FNAC was performed us-
ing a 23-gauge needle attached to a 10-ml syringe. Two 
to three aspirations were performed on each nodule and 
cytology smears prepared for analysis. FNAC cases that 
were non-diagnostic were included in the final analysis 
only if surgical histopathology was available. 
Statistical analysis
Collected data was entered into a Microsoft Excel data 
sheet and were analysed using the SPSS 25 version soft-
ware. Specificity, sensitivity, and positive and negative 
predictive value (with 95% confidence interval [95% CI]) 
were calculated and used to evaluate the reliability of TI-
RADS in differentiation between benign and malignant 
features. The odds ratio was determined to quantify how 
strongly the presence or absence of a particular suspicious 
ultrasound feature was associated with malignancy in the 
study population. The p values were measured using Stu-
dent’s t-test. In all analyses, p < 0.05 was taken to indicate 
statistical significance.
Results
Of a total of 127 nodules included in this study, 110 nod-
ules were from females (86.6%) and 17 from males (13.4%), 
with a male-to-female ratio of 1 : 6.4. We observed a slightly 
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higher female-to-male ratio in our study, but our study only 
represented the values obtained from a single hospital and 
was not a multicentric study. Out of 127 nodules studied 
104 nodules were benign (94 nodules in females, 10 nod-
ules in males) and 23 nodules were malignant (16 nodules 
in females, seven nodules in males). Malignancy was more 
common among male patients who presented with a thy-
roid nodule (not statistically significant, p = 0.084). There 
was no significant difference in the mean age of patients 
with benign (mean age was 46.6 ±13.3 years) and malig-
nant thyroid nodules (mean age was 47.3 ±12.6 years) 
(p = 0.818). 
ACR-TI-RADS
We found that the risk of malignancy increased as the 
ACR-TI-RADS category increased. The risk of malignan-
cy in ACR TI-RADS category 1 and 2 were found to be 
0%, 6.9% in category 3, 30.9% in category 4, and 77.7% 
in category 5.
Kwak TIRADS
None of the nodules assessed in our study could be cat-
egorised into Kwak TI-RADS 5. Similarly, TI-RADS 1 
refers to normal thyroid according to Kwak TI-RADS. 
Barring these two categories, we found in our study that 
the risk of malignancy significantly rose as the TI-RADS 
category increased. The risk of malignancy in TI-RADS 
categories 2 and 3 was found to be 0%, 21.5% in catego-
ry 4A, 32.4% in category 4B, and 100.0% in category 4C 
(Tables 1 and 2). 
In our study sonological features that showed a signifi-
cant association with malignancy were solid composition, 
Table 1. Cross tabulation depicting nodule distribution in Kwak and ACR TI-RADS
Kwak 
TI-RADS
ACR TI-RADS Total
TR1 TR2 TR3 TR4 TR5
TI-RADS 2 Benign 6 0 0 0 0 6
TI-RADS 3 Probably benign 0 26 10 3 0 39
TI-RADS 4A Low suspicion of malignancy 0 1 27 22 1 51
TI-RADS 4B Intermediate suspicion of malignancy 0 0 6 16 6 28
TI-RADS 4C Moderate suspicion of malignancy 0 0 0 0 3 3
Total 6 27 43 41 10 127
Table 2. Frequency of ultrasound features of thyroid nodules according to ACR-TI-RADS descriptors
Ultrasound feature Benign Malignant Total Risk of malignancy (%)
Composition Cystic or predominantly cystic 2 0 2 0
Spongiform 4 0 4 0
Mixed solid-cystic 44 0 44 0
Solid or predominantly solid 54 23 77 29.8
Echogenicity Anechoic 3 0 3 0
Hyperechoic or isoechoic 89 6 95 6.3
Hypoechoic 8 16 24 66.6
Very hypoechoic 0 1 1 100
Shape Wider than tall or round 98 20 118 16.9
Taller than wide 2 3 5 60.0
Margin Smooth 79 16 95 16.8
Ill-defined 16 4 20 20.0
Lobulated or irregular 4 3 7 42.8
Extra-thyroidal extension 1 0 1 0
Echogenic foci None/large comet tail artefact 66 10 76 13.1
Macrocalcifications 21 6 27 22.2
Peripheral rim calcification 11 3 14 21.4
Punctate echogenic foci 2 4 6 66.6
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hypoechogenicity, and calcification including microcalcifi-
cation. Out of the suspicious sonological features hypoecho-
genicity and microcalcification showed the highest positive 
predictive value (PPV) (66.7%) for malignancy (Table 3).
Estimation of decrease in unnecessary fine-needle 
aspiration cytologies using TIRADS
Using Kwak TI-RADS all nodules characterised un-
der category 2 and 3 were benign on cyto/histopathology. 
Therefore, the specificity of TI-RADS categories 2 (4.7%) 
and 3 (30.7%) in labelling a nodule as benign was found to 
be 100%. The estimated decrease in unnecessary FNACs 
in our study was found to be 35.43%.
Specificity of ACR TI-RADS category TR1 and TR2 in 
labelling a nodule as benign was also found to be 100%. 
By avoiding these nodules the estimated decrease in un-
necessary FNACs in our study would have been 25.98%.
Discussion
In 2005 the Society of Radiologists in Ultrasound (SRU) 
published their guidelines to help in deciding which thy-
roid nodules needed FNA and which that did not [10]. 
Subsequently, many other studies have proven the use-
fulness of ultrasound evaluation of thyroid nodules and 
its ability to differentiate benign from malignant nodules 
[3-5,11-17]. Also, professional societies brought forth 
their guidelines, which either focused on or included 
suggestions for use of ultrasonographic findings in deter-
mining whether a nodule required FNA [18-22]. All these 
guidelines were chiefly built upon sonographic appear-
ance and nodule size. The ultrasonographic appearance 
is important because it lends information pertaining to 
risk of malignancy. To predict with complete certainty if 
a nodule is malignant or benign is not attainable, even 
if strong trends exist based on ultrasonographic features. 
Some nodules that appear malignant will turn out to be 
benign, and some that appear benign will end up being 
malignant. To diagnose all thyroid malignancies, we will 
have to preform biopsy on all thyroid nodules, which is 
impractical and invasive. Recognising the fact that some 
thyroid malignancies might be missed, our goal should 
be in increasing the detection of significant cancers while 
reducing the FNA of benign nodules. Nodule size is sig-
nificant because it is inversely related to prognosis [23]. 
Therefore, most guidelines suggest FNA from large nod-
ules even if the risk of malignancy is low.
Most of the guidelines are complex, employing sev-
eral sonography features and formulae that are not easy 
to use in daily practice. We investigated the TI-RADS 
classification proposed by Kwak et al., which is simple 
and similar to the BI-RADS system that has been in use 
for many years and is familiar to most radiologists. Kwak 
et al. found various independent ultrasonographic fea-
tures that were significantly associated with malignancy. 
These included hypoechogenicity, marked hypoecho-
genicity, taller than wide shape, micro calcifications, mi-
crolobulated or irregular margins, and solid composition. 
We also compared our results with those obtained by 
Srinivas et al. [8] and Chandramohan et al. [9], who also 
evaluated the efficacy of Kwak TI-RADS in differentiating 
benign and malignant nodules (see Table 4). Our results 
Table 3. Statistical results of suspicious ultrasound features
Feature Sensitivity (%) Specificity (%) PPV (%) NPV (%) PLR NLR OR P
Solid composition 100 48 29.8 100 1.9 0.0 43.5 0.008*
Irregular + ill-defined margin * 30.4 80.7 25.9 84.0 1.5 0.8 1.8 0.239
Irregular margin* 13.0 96.1 42.8 83.3 3.3 0.9 3.7 0.09
Ill-defined margin* 17.3 84.6 20.0 82.2 1.1 0.9 1.1 0.8
Taller than wide 8.7 98.0 50.0 82.9 4.5 0.9 4.85 0.12
Micro-calcification 17.4 98.0 66.6 84.3 9.0 0.8 10.7 0.008*
Calcification 56.5 66.9 27.6 87.3 1.7 0.6 2.63 0.039*
Macro-calcification 26.0 79.8 22.2 83.0 1.29 0.9 1.39 0.53
Peripheral rim calcification 8.7 89.4 15.3 81.5 0.8 1.0 0.8 0.26
Hypoechoic 69.5 92.0 66.7 92.9 8.7 0.3 26.2 < 0.0001*
*In our study, while categorising lesions based on Kwak TI-RADS, we considered the margin characteristic ‘ill-defined’ along with irregular margins, similarly to studies by Srinivas et al. and 
Chandramohan et al., who also evaluated Kwak TI-RADS. Kwak et al. and ACR-TI-RADS do not mention ill-defined margin as suspicious feature.
Table 4. Comparison of malignancy risk according to various studies that 
employed Kwak TI-RADS
TI-
RADS
Risk of malignancy [%]
Kwak 
et al. 
Kwak 
et al. 
Chandramohan 
et al.
Srinivas 
et al.
Our 
study
1 0 0 0
2 0 6.6 0 0
3 1.7 7.3 32 0.64 0
4A 3.3 8.3-96.6 36 4.76 21.5
4B 9.2 64 66.67 32.4
4C 44.4-72.4 59 83.33 100
5 87.5 91 100
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suggest that the following independent sonological fea-
tures are significantly associated with malignant cytology: 
solid composition, hypoechogenicity, and the presence of 
calcifications (including microcalcifications).
Many authors have stratified the risk of each TIRADS 
category separately. Though, there were differences in 
these values, they all followed a common pattern, with the 
risk of malignancy increasing from TIRADS 2 through 
TIRADS 5 category.
Kwak et al. had observed that irregular margins had 
the highest odds ratio for malignancy followed by taller 
than wide shape, marked hypoechogenicity, micro calci-
fication, and solid composition of a thyroid nodule. We 
observed that solid composition had highest odds ratio, 
followed by hypoechogenicity and micro calcifications. 
Hypoechogenicity was considered one of the features 
of malignancy by Horvath et al. [3] and Kwak et al. [5] 
though the latter included only marked hypoechogenic-
ity for TIRADS categorization. In our study we found 
hypoechogenicity to be a strong independent predictor 
of malignancy. Studies by Kwak et al. and Chandramo-
han et al. also found statistically significant association of 
hypoechogenicity with malignancy. On the other hand, 
Srinivas et al. found no relation between hypoechogenic-
ity and malignancy (Table 5).
Also, we analysed 28 4B nodules that were present in 
our study, of which nine were malignant. The presence 
of hypoechogenicity appears to be a strong predictor of 
malignancy in Kwak TI-RADS-4B. Six out of the nine 
malignant nodules in TI-RADS 4B had hypoechogenic-
ity, whereas only three out of 19 benign nodules had 
hypoechogenicity. Sensitivity of hypoechogenicity for 
identifying 4B malignant nodules was 66.67%, specific-
ity 84.2%, positive likelihood ratio 4.2, PPV 66.67%, and 
NPV 84.2%. Our sample size was only 127. Also, the per-
centage of nodules that were malignant (18.1%) in our 
study was quiet high, probably due to our institution be-
ing a tertiary care referral centre. Hence, the discrepan-
cies arising due to the disparity in frequency of malignant 
nodules may also have contributed to hypoechogenicity 
being a relevant finding in our study.
Even though microcalcification is a strong predictor 
of malignancy, we found the presence of calcification 
alone (either macrocalcification/peripheral rim calcifi-
cation/microcalcification) to be an independent strong 
predictor of malignancy (Table 6). Vinayak and Sande 
in their study found that all 14 of the studied thyroid le-
sions with macrocalcifications were benign [24]. A point 
to be noted here is that macrocalcification casts a dense 
posterior acoustic shadow and might impair proper eval-
uation of the nodule; hence, we cannot say with certainty 
that other echogenic foci, especially microcalcifications, 
were absent. 
Bonavita et al. in their study observed that the pres-
ence of hyperechogenicity or the – white knight appear-
ance was 100% sensitive for a nodule to be benign [25]. 
We found that the odds ratio for a lesion that is either 
isoechoic or hyperechoic being benign was 16.81 (95% CI: 
5.71-49.48) (p < 0.0001). 
Hoang et al. noted that although a cystic component 
occurs in 13-26% of all thyroid malignancies, a predom-
inantly cystic appearance is uncommon [26]. Popli et al. 
in their study observed that all of the four cystic nodular 
lesions and seven lesions that showed hyperechogenic-
ity in their study were found to be benign on FNAC 
[27]. Horvath et al. in their study found that anechoic, 
non-vascularised lesions with hyperechoic spots classi-
fied as a colloid type 1 lesion were found to have 0% risk 
of malignancy. In our study all the 50 nodules that had 
mixed solid-cystic component or predominantly cystic 
component presented benign cytopathology. Malignancy 
was seen only among solid nodules. Hence, our study is 
concordant with the fact that malignancy is uncommon 
in predominantly cystic lesions.
We also evaluated the risk stratification system pro-
posed by the American College of Radiology Thyroid Im-
aging Reporting and Data System (ACR-TI-RADS) [6]. 
The ACR-TI-RADS committee classified thyroid nodules 
into five risk levels according to their ultrasonograph-
ic features. The ACR-TI-RADS uses a system based on 
allocating points for different ultrasonographic features 
of nodules in five morphologic categories (composition, 
echogenicity, margins, echogenic foci, and shape).The 
point system may seem cumbersome compared with an 
approach based on pattern recognition, but the advantage 
of point systems is that they are relatively easy to use and 
Table 5. Comparison of statistical results analysing the significance of hy-
poechogenicity between various studies
Suspicious ultrasound feature Malignant nodule Total
Present Absent
Hy
po
ec
ho
ge
nic
ity
Present
Kwak et al. 169 508 677
Chandra-
mohan et al.
41 24 65
Srinivas et al. 5 88 93
Our study 16 8 24
Absent
Kwak et al. 106 875 981
Chandra-
mohan et al.
77 130 207
Srinivas et al. 20 252 272
Our study 7 96 103
Hy
po
ec
ho
ge
nic
ity
Kwak 
et al.
Chandra-
mohan et al.
Srinivas 
et al.
Our 
study
Sensitivity (%) 61.4 34.7 20.0 69.5
Specificity (%) 63.2 84.4 74.1 92.0
PPV (%) 24.9 63.0 5.3 66.7
OR 2.7 2.8 0.7 26.2
P < 0.0001* 0.0003* 0.51 < 0.0001*
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can be integrated into practices with varying volumes of 
patients with thyroid nodules and practices with varying 
levels of professional expertise. At least this approach 
forces the person who is obtaining and interpreting the 
thyroid images to focus his or her attention on each of the 
five important morphologic categories. Another benefit is 
that if future data ascribe previously unrecognised signifi-
cance to sonographic findings, those findings can be easily 
incorporated into the ACR TI-RADS. A limitation of the 
point-based system is that certain findings have different 
implications, depending on other associated findings.
The TR1 and TR2 nodules have a risk of malignancy 
lower than 2%, and FNA was not recommended for these 
nodules. The TR3, TR4, and TR5 nodules were predicted 
to have a risk of malignancy of less than 5%, 5.1-20%, and 
greater than 20%, respectively, with FNA recommended for 
those nodules with threshold sizes of 2.5, 1.5, and 1.0 cm, 
respectively. 
We did not follow ACR guidelines (neither category 
nor size criterion) while advising FNA correlation to ret-
rospectively assess the impact in reducing unwarranted 
FNACs that are routinely being performed (Table 7).
Kwak vs. ACR-TI-RADS
Kwak TI-RADS 2 and 3 had higher sensitivity in predicting 
benignity compared to ACR TR1 and 2 (43.2% vs. 31.7%), 
thus being slightly better in predicting unnecessary FNAC.
PPV of Kwak TI-RADS 4 (including 4A + 4B + 4C) 
in assessing malignancy was 28.05%, with a sensitivity of 
100% and specificity of 43.27%. PPV of TR4 and TR5 in 
assessing malignancy was 23.8%, with a sensitivity of 86.9% 
and specificity of 53.2%.
Conclusions
We found TI-RADS classification (both ACR and Kwak 
TI-RADS) to be a reliable, noninvasive, and practical 
method for assessing thyroid nodules in routine practice. 
Both TI-RADS classifications can safely avert avoidable 
FNACs in a significant proportion of benign thyroid 
lesions. Being a point-based system and also being amena-
ble to future modifications, we prefer the use of ACR- 
TI-RADS.
Limitations
The sample size was limited due to the time-bound nature 
of the study.
The lengths of experience of the observers were not 
uniform. Analysis of interobserver variability was not con-
ducted.
False negative and false positive cytology may have 
had an impact on the results obtained.
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